Skip to content
DraconiticResearch
Search Sources API
190,851 studies31 sourcesUpdated 49 min ago
Peer-reviewedPublisher termsRSC Medicinal Chemistry

Development of phenothiazine-based inhibitors towards drug-resistant glioblastoma

  1. 1Department of Chemistry, Indian Institute of Technology Gandhinagar Palaj Campus, Palaj Gandhinagar-382055 Gujarat India

Related

  1. Treatment Sequencing in ARPI-Pre-Exposed Metastatic Castration-Resistant Prostate Cancer: Radioligand Therapy, PARP Inhibitors, and Antibody-Drug Conjugates.
    Baha Sharaf, Mohammad Al-Rwashdeh, Osama El Khatib +6
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Collagen-dependent DDR1 ectodomain shedding regulates proliferative signaling in radiation-resistant glioblastoma
    S. Dunlap, C. A. Harvey, A. Elkholy +8
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  3. Single-cell RNA sequencing combined with artificial intelligence to uncover immunotherapy biomarkers and decipher drug resistance mechanisms in glioblastoma.
    Tao Fu, Mengwan Hu, Xian Wu
    Frontiers in oncologyPeer-reviewedCC BYFull textHuman geneticsEurope PMCCrossref
  4. Sporadic Multiple Meningiomas Presenting With Drug-Resistant Seizures in a Young Adult: A Case Report
    Meryem Amghar, Zakariae Benyaich, Mohamed Lmejjati
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Epilepsy Surgery vs Medical Management for Pediatric Drug-Resistant Focal Epilepsy
    T. Abel, E. Harford, D. A. Silliman +3
    medRxivPreprintAll rights reservedFull textNeurologymedRxiv
BibTeX
@article{rai2026development,
  title = {{Development of phenothiazine-based inhibitors towards drug-resistant glioblastoma}},
  author = {Gaurav Rai and Deepika Khasa and Sivapriya Kirubakaran},
  journal = {RSC Medicinal Chemistry},
  year = {2026},
  month = aug,
  doi = {10.1039/d6md00465b},
  url = {https://doi.org/10.1039/d6md00465b},
}
RIS
TY  - JOUR
TI  - Development of phenothiazine-based inhibitors towards drug-resistant glioblastoma
AU  - Gaurav Rai
AU  - Deepika Khasa
AU  - Sivapriya Kirubakaran
PY  - 2026
DA  - 2026/08/27
JO  - RSC Medicinal Chemistry
DO  - 10.1039/d6md00465b
UR  - https://doi.org/10.1039/d6md00465b
SN  - 2632-8682
ER  -